New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that cause COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic.
Immune cell implicated in development of lung disease following viral infection – Washington University School of Medicine in St Louis wustl.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wustl.edu Daily Mail and Mail on Sunday newspapers.
Three new, fast-spreading variants of the virus that causes COVID-19 can evade antibodies that work against the original form that sparked the pandemic, new research shows.
With few exceptions, whether the antibodies were produced in response to vaccination or natural infection, or were purified antibodies intended for use as drugs, researchers found they needed more antibody to neutralize the new variants.
The findings, from laboratory-based experiments, suggest that COVID-19 drugs and vaccines developed thus far may become less effective as the new variants become dominant, as experts say they inevitably will. The researchers looked at variants from South Africa, the United Kingdom, and Brazil.